Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Automation solution provider announces organizations selected CrystalMation
April 19th, 2005
RoboDesign International, Inc., a wholly owned subsidiary of Rigaku/MSC announced that the International AIDS Vaccine Initiative (IAVI), in collaboration with the Joint Center for Structural Genomics (JCSG) and The Scripps Research Institute (TSRI), has chosen the CrystalMation system as its standard crystal screen platform. CrystalMation is a modular and fully automated protein crystallization platform, which includes systems for liquid handling, low volume dispense, imaging, storage and analysis. In pursuing structures of neutralizing antibodies and complexes with highly glycosylated HIV envelope proteins for the IAVI Neutralizing Antibody...
Source: Cancer Weekly (2005-04-19)
|
